IMX-110 in Patients With Advanced Solid Tumors
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03382340 |
Recruitment Status :
Active, not recruiting
First Posted : December 22, 2017
Last Update Posted : September 28, 2023
|
Sponsor:
Immix Biopharma Australia Pty Ltd
Information provided by (Responsible Party):
Immix Biopharma, Inc. ( Immix Biopharma Australia Pty Ltd )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | October 31, 2023 |
Estimated Study Completion Date : | December 31, 2023 |